Clinical Trial Update: Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial [Phase 2]

View source ↗

Summary

This update describes a Phase 2 trial to assess the safety and feasibility of Botensilimab and Balstilimab given before surgery for clear cell renal cell carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• Balstilimab (balstilimab)
• Botensilimab (botensilimab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8 | Phase 2 | Status: NOT_YET_RECRUITING